Boston Celtics fund first teen vaccination delivery program in the country

November 06, 2006

Providence, RI - Reflecting a long-standing commitment to the youth in New England, The Miriam Hospital and Boston Celtics have teamed up to develop the Boston Celtics "Team Vaccinates Teens" program - the first program in the country that will test and explore vaccine delivery strategies to adolescents.

Highly safe and effective vaccines that can prevent Human Papilloma Virus (HPV) and other sexually transmitted diseases are only beneficial if they are successfully dispersed to the critical age group of adolescents. Through a $25,000 grant from The Boston Celtics Shamrock Foundation, researchers at The Miriam Hospital will collaborate with organizations distributing the HPV vaccine to adolescents at high-risk for contracting the disease. The goal of "Team Vaccinates Teens" is for researchers to learn what structures are effective for engaging youth in an extended vaccination program, creating a model that will eventually allow for delivery of an HIV vaccine once one becomes available.

For more than ten years, The Miriam Hospital has been one of the 30 sites in the world that is researching and testing HIV vaccines for adults in the HIV Vaccine Trials Network (HVTN). It is expected that HIV vaccine trials will be open to adolescents in approximately two to four years.

"The goal - which we believe it is achievable - is to license and deliver an effective HIV vaccine within ten years," said Michelle Lally, MD, medical director of the HIV vaccine trials at The Miriam Hospital. "However, if an effective HIV vaccine was approved tomorrow, we would not be able to successfully administer it to the youth in New England without a distribution plan in place. This generous grant allows us to start to test vaccine modalities among adolescents so when anticipated vaccines become available, we can efficiently deliver them to high-risk youth."

"The Boston Celtics Shamrock Foundation is proud to collaborate with The Miriam Hospital to create the first program in the nation to test vaccine delivery methods to high-risk youth," said Stephen Lewinstein, part-owner of the Boston Celtics. "With half of all diagnosed AIDS patients today under the age of 25, a safe and effective vaccine is the best way to control the spread of this deadly disease. Through the combined strengths of those involved in the 'Team Vaccinates Teen' program, we will ensure that when a HIV vaccine is approved it will make a significant and direct impact on infection rates in adolescents."

Although participation in adult HIV vaccine trials has increased in recent years, several misconceptions about the trials remain that researchers expect to hinder adolescent participation. Among the most popular inaccuracy is that a potential HIV vaccine can cause a participant to contract the disease, which is impossible. Since the adolescents targeted in "Team Vaccinates Teens" are also potential candidates for future HIV vaccine trials, this program will help researchers move toward implementation of an HIV vaccine program for high-risk youth that minimizes or eliminates barriers to participation.
The Miriam Hospital ( is a not-for-profit hospital affiliated with Brown Medical School and a founding member of the Lifespan health system. Founded in 1926 by the Miriam Hospital Women's Association, The Miriam offers particular expertise in cardiology; oncology; and HIV/AIDS treatment, research and prevention. Nationally recognized as a top hospital in cardiovascular care, The Miriam is home to the only Women's Cardiac Center in the region and JCAHO certified Primary Stroke Center. The Miriam Hospital has been awarded Magnet Recognition for Excellence in Nursing Services three times and is committed to excellence in patient care, research and medical education.


Related HIV Vaccine Articles from Brightsurf:

New HIV vaccine combination strategy provides better and more durable protection
Emory researchers and their colleagues have shown a new HIV vaccine is better at preventing infection and lasts longer.

Rectal microbes influence effectiveness of HIV vaccine
Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines, according to researchers at UC Davis.

New sequencing study provides insight into HIV vaccine protection
Scientists led by the US Military HIV Research Program (MHRP) identified a transcriptional signature in B cells associated with protection from SIV or HIV infection in five independent trials of HIV-1 vaccine candidates.

HIV vaccine nears clinical trial following new findings
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.

New HIV vaccine strategy 'pumps' the immune system
A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model.

HIV vaccine protects non-human primates from infection
New research shows that an experimental HIV vaccine strategy works in non-human primates.

Special antibodies could lead to HIV vaccine
Around one percent of people infected with HIV produce antibodies that block most strains of the virus.

Scientists took another step towards creating an HIV vaccine
Scientific group of Peter the Great St. Petersburg Polytechnic University headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.

New molecule shows promise in HIV vaccine design
Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV.

Read More: HIV Vaccine News and HIV Vaccine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to